Pharvaris (PHVS) Accumulated Expenses (2019 - 2026)
Pharvaris (PHVS) posted Accumulated Expenses of $28.35 trillion for Q2 2026, compared with $21.96 million a year earlier and up 27.1% from the prior quarter.
Pharvaris (PHVS) Accumulated Expenses (2019 - 2026) Analysis & Trends
At the end of FY2025, Pharvaris' Accumulated Expenses came in at $26.38 trillion, up 38.6% from FY2024.
- Annual Accumulated Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 38.9% (FY2020 to FY2025).
- In prior years, Pharvaris' Accumulated Expenses was $19.04 trillion in FY2024 (+59.0%), $11.97 trillion in FY2023 (+4.3%), $11.48 trillion in FY2022 (+127.2%) and $5.05 trillion in FY2021 (-0.9%).
- The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2019.
- On a year-over-year basis, Accumulated Expenses increased in three of the last six quarters, with an average decline of 31.9%.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2022, with growth of 137.5%; the weakest was Q2 2025, with a decline of 100.0%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $22.3 trillion (Q1 2026), $27.18 trillion (Q4 2025) and $26.51 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Pharvaris | 2.07 Bn | -289,124.33 Bn | 85,072.10 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28,349.37 Bn |
| Mar 31, 2026 | 22,298.15 Bn |
| Dec 31, 2025 | 27,178.64 Bn |
| Sep 30, 2025 | 26.51 Mn |
| Jun 30, 2025 | 21.96 Mn |
| Mar 31, 2025 | 18.05 Mn |
| Dec 31, 2024 | 18,794.89 Bn |
| Sep 30, 2024 | 13,261.71 Bn |
| Jun 30, 2024 | 17,076.87 Bn |
| Mar 31, 2024 | 13,198.78 Bn |
| Dec 31, 2023 | 11,907.98 Bn |
| Sep 30, 2023 | 12,502.74 Bn |
| Jun 30, 2023 | 11,151.58 Bn |
| Mar 31, 2023 | 10,608.83 Bn |
| Dec 31, 2022 | 11,111.26 Bn |
| Sep 30, 2022 | 10.21 Mn |
| Jun 30, 2022 | 9.58 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 4,884.85 Bn |
| Sep 30, 2021 | 4.30 Mn |
Pharvaris Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();